Bellevue Group Ag Ionis Pharmaceuticals Inc Transaction History

Bellevue Group Ag

$6.38 Billion
Q1 2024

A detailed history of Bellevue Group Ag transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bellevue Group Ag holds 8,299,514 shares of IONS stock, worth $312 Million. This represents 5.64% of its overall portfolio holdings.

Number of Shares

8,299,514

Previous 8,713,987 4.76%

Holding current value

$312 Million

Previous $441 Million 18.39%

% of portfolio

5.64%

Previous 6.84%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $17.4 Million - $22.2 Million	-414,473 Reduced 4.76%	8,299,514 $360 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $22.6 Million - $26.8 Million	-519,713 Reduced 5.63%	8,713,987 $441 Million
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $5.64 Million - $6.91 Million	-146,600 Reduced 1.56%	9,233,700 $419 Million
Q2 2023 Aug 14, 2023	SELL	$34.73 - $43.33 $4.57 Million - $5.7 Million	-131,600 Reduced 1.38%	9,380,300 $385 Million
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $7.79 Million - $9.56 Million	-232,000 Reduced 2.38%	9,511,900 $340 Million

Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $10.4 Million - $13 Million	280,500 Added 2.96%	9,743,900 $368 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $11.4 Million - $15.2 Million	-313,128 Reduced 3.2%	9,463,400 $419 Million
Q2 2022 Aug 11, 2022	SELL	$31.71 - $43.0 $4.49 Million - $6.09 Million	-141,545 Reduced 1.43%	9,776,528 $362 Million
Q1 2022 May 13, 2022	SELL	$29.88 - $37.04 $13.1 Million - $16.2 Million	-437,050 Reduced 4.22%	9,918,073 $367 Million
Q4 2021 Feb 10, 2022	BUY	$25.61 - $35.1 $25.8 Million - $35.4 Million	1,007,197 Added 10.77%	10,355,123 $315 Million
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $19.5 Million - $23.6 Million	-582,319 Reduced 5.86%	9,347,926 $314 Million
Q2 2021 Aug 12, 2021	BUY	$34.54 - $47.25 $32.7 Million - $44.7 Million	946,011 Added 10.53%	9,930,245 $396 Million
Q1 2021 May 12, 2021	SELL	$42.51 - $63.78 $2.8 Million - $4.2 Million	-65,858 Reduced 0.73%	8,984,234 $404 Million
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $15.1 Million - $20.1 Million	333,822 Added 3.83%	9,050,092 $512 Million
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $22.1 Million - $29.4 Million	466,397 Added 5.65%	8,716,270 $414 Million
Q2 2020 Aug 13, 2020	SELL	$46.85 - $61.05 $6.08 Million - $7.92 Million	-129,769 Reduced 1.55%	8,249,873 $486 Million
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $2.17 Million - $3.31 Million	-52,178 Reduced 0.62%	8,379,642 $396 Million
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $5.92 Million - $7.17 Million	109,906 Added 1.32%	8,431,820 $509 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $21.5 Million - $26.3 Million	364,786 Added 4.58%	8,321,914 $499 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $475 Million - $659 Million	7,654,485 Added 2529.21%	7,957,128 $511 Million
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $4.23 Million - $6.49 Million	-79,945 Reduced 20.9%	302,643 $24.6 Million
Q4 2018 Feb 12, 2019	BUY	$43.37 - $59.54 $3.12 Million - $4.29 Million	72,052 Added 23.2%	382,588 $20.7 Million
Q3 2018 Nov 13, 2018	SELL	$42.88 - $53.7 $516,704 - $647,085	-12,050 Reduced 3.74%	310,536 $16 Million
Q2 2018 Aug 07, 2018	BUY	$40.53 - $50.7 $421,512 - $527,280	10,400 Added 3.33%	322,586 $13.4 Million
Q1 2018 May 09, 2018	BUY	$44.08 - $55.05 $2.45 Million - $3.05 Million	55,480 Added 21.61%	312,186 $13.8 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $452,700 - $579,510	-9,000 Reduced 3.39%	256,706 $12.9 Million
Q3 2017 Nov 13, 2017	BUY	$45.56 - $59.57 $1.87 Million - $2.45 Million	41,144 Added 18.32%	265,706 $13.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	224,562	224,562 $11.4 Million

Others Institutions Holding IONS

# of Institutions

396

Shares Held

122M

Call Options Held

854K

Put Options Held

464K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.33B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Ionis Pharmaceuticals Inc Transaction History